Cory Kasimov

J.P. Morgan Weighs In on Two Healthcare Giants: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG)

J.P.

Jason Cohen Jason Cohen — October 23, 2015, 4:06 PM EDT

J.P. Morgan Weighs In on ZIOPHARM Oncology Inc. Following New Collaboration with Intrexon

J.P.

Jason Cohen Jason Cohen — September 29, 2015, 3:08 PM EDT

J.P. Morgan Reiterates Overweight on Keryx Biopharmaceuticals Following Investor Meetings with Management

In a research report issued Friday, J.P.

Jason Cohen Jason Cohen — September 25, 2015, 4:05 PM EDT

J.P. Morgan Maintains Overweight on Juno Therapeutics Inc Following Investor Meetings

In a research report released today, J.P.

Jason Cohen Jason Cohen — September 16, 2015, 3:56 PM EDT

Analysts Remain Bullish on Sangamo Biosciences, Inc. (SGMO) Following Restructuring Collaboration Announcement

Yesterday, Sangamo Biosciences, Inc. (NASDAQ:SGMO) announced it will be restructuring its collaboration with Shire PLC (ADR) (NASDAQ:SHPG) in order to speed up the …

Sarah Roden Sarah Roden — September 3, 2015, 10:15 AM EDT

J.P. Morgan Reiterates Bullish Stance on Incyte Corporation (INCY) Following Global License Agreement with Jiangsu Hengrui Medicine

J.P.

Jason Cohen Jason Cohen — September 2, 2015, 10:07 AM EDT

J.P. Morgan Reiterates Overweight on bluebird bio Inc Following Investor Meetings with Management

J.P.

Jason Cohen Jason Cohen — August 20, 2015, 10:31 AM EDT

J.P. Morgan Cuts Price Target for Juno Therapeutics Inc (JUNO) Following 2Q:15 Results

J.P.

Jason Cohen Jason Cohen — August 13, 2015, 11:26 AM EDT

J.P. Morgan Reiterates Neutral on Ziopharm Oncology Inc Following 2Q Results

J.P.

Jason Cohen Jason Cohen — August 12, 2015, 10:51 AM EDT

J.P. Morgan Raises Price Target for Novavax, Inc. on Back of RSV Phase 2 Trial Data

In a research report released Tuesday, J.P.

Jason Cohen Jason Cohen — August 11, 2015, 12:04 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts